Agenus
AGEN
#9163
Rank
NZ$0.18 B
Marketcap
NZ$5.12
Share price
-4.67%
Change (1 day)
-14.38%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-118.38%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.27 Billion-5.5%
2022 -NZ$0.29 Billion-556.26%
2021 NZ$61.95 M-130.37%
2020 -NZ$0.21 Billion73.75%
2019 -NZ$0.12 Billion-48.74%
2018 -NZ$0.23 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.19 Billion26.55%
2015 -NZ$0.15 Billion110.24%
2014 -NZ$69.05 Million49.12%
2013 -NZ$46.3 Million
2011 -NZ$31.97 Million-12.25%
2010 -NZ$36.44 Million-21.41%
2009 -NZ$46.36 Million-26.86%
2008 -NZ$63.38 Million13.72%
2007 -NZ$55.74 Million-33.4%
2006 -NZ$83.69 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$96.09 Million37.83%
2001 -NZ$69.72 Million55.99%
2000 -NZ$44.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.25 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.67 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.45 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.61 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.43 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA